Seres Therapeutics (MCRB) just unveiled an announcement.
Seres Therapeutics, Inc. has entered into an Asset Purchase Agreement with Nestlé’s subsidiary SPN, marking a significant move in the biopharmaceutical industry. Investors and interested parties can look forward to a conference call scheduled for August 6, 2024, at 8:30 a.m. Eastern Time, which will provide further details about this strategic transaction.
See more data about MCRB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com